Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Grippostad C
- Development stage
- Unknown
- Lead developer
- STADA
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Grippostad C is an over-the-counter combination medication developed by STADA Arzneimittel AG for the symptomatic treatment of common colds and flu-like infections. It is formulated as a small molecule oral medication containing four active ingredients: paracetamol (analgesic and antipyretic), chlorphenamine maleate (antihistamine), caffeine (analgesic adjuvant and stimulant), and ascorbic acid (Vitamin C). Paracetamol provides pain relief and fever reduction by inhibiting prostaglandin G/H synthase 1 and 2. Chlorphenamine maleate targets the histamine H1 receptor to alleviate nasal congestion and mucus secretion. Caffeine acts as an antagonist at adenosine A1 and A2a receptors and inhibits phosphodiesterase, which enhances the analgesic effect of paracetamol and counteracts antihistamine-induced drowsiness. Ascorbic acid serves as an antioxidant to support immune function during infection. The product is available in various oral forms, including hard capsules and drinking granules.
- Brand names
- Grippostad C
- Other names
- paracetamol + ascorbic acid + caffeine + chlorphenamine maleate
02
Targets
ADORA1 (Adenosine receptor A1 subtype)ADORA2A (Adenosine A₂A Receptor)HRH1 (Histamine H1 Receptor)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PDE (Phosphodiesterase family)
Beyond the preview
Go deeper on Grippostad C.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Grippostad C.